DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,812,880 | +0.0% | 297,513 | -3.2% | 0.06% | 0.0% |
| Q2 2023 | $73,788,663 | -6.9% | 307,453 | -2.2% | 0.06% | -10.0% |
| Q1 2023 | $79,269,328 | -7.8% | 314,511 | -2.9% | 0.07% | -15.7% |
| Q4 2022 | $85,999,715 | +3.6% | 324,014 | +0.8% | 0.08% | -4.6% |
| Q3 2022 | $82,989,000 | +0.6% | 321,300 | -1.2% | 0.09% | +7.4% |
| Q2 2022 | $82,469,000 | -13.9% | 325,294 | -0.3% | 0.08% | -3.6% |
| Q1 2022 | $95,734,000 | -13.9% | 326,367 | -3.5% | 0.08% | -8.7% |
| Q4 2021 | $111,217,000 | +11.2% | 338,031 | +2.8% | 0.09% | -1.1% |
| Q3 2021 | $100,059,000 | +14.0% | 328,666 | +0.5% | 0.09% | +16.2% |
| Q2 2021 | $87,787,000 | +17.4% | 327,124 | -1.5% | 0.08% | +9.6% |
| Q1 2021 | $74,759,000 | -1.5% | 332,141 | -2.8% | 0.07% | -5.2% |
| Q4 2020 | $75,927,000 | +5.8% | 341,791 | +2.5% | 0.08% | -12.5% |
| Q3 2020 | $71,778,000 | +19.8% | 333,338 | -1.6% | 0.09% | +10.0% |
| Q2 2020 | $59,913,000 | +18.8% | 338,819 | -7.0% | 0.08% | +27.0% |
| Q1 2020 | $50,447,000 | -63.3% | 364,457 | -59.3% | 0.06% | -53.3% |
| Q4 2019 | $137,320,000 | +11.2% | 894,707 | +4.7% | 0.14% | +9.8% |
| Q3 2019 | $123,439,000 | -0.3% | 854,662 | -1.3% | 0.12% | +1.7% |
| Q2 2019 | $123,765,000 | +2.3% | 865,976 | -5.5% | 0.12% | 0.0% |
| Q1 2019 | $120,938,000 | +26.2% | 916,053 | -1.4% | 0.12% | +13.1% |
| Q4 2018 | $95,800,000 | -0.1% | 929,009 | +5.3% | 0.11% | +17.6% |
| Q3 2018 | $95,853,000 | +25.1% | 882,131 | +13.7% | 0.09% | +19.7% |
| Q2 2018 | $76,592,000 | +162.4% | 776,159 | +160.4% | 0.08% | +162.1% |
| Q1 2018 | $29,185,000 | +6.3% | 298,072 | +0.8% | 0.03% | +7.4% |
| Q4 2017 | $27,448,000 | +4.7% | 295,687 | -3.2% | 0.03% | 0.0% |
| Q3 2017 | $26,211,000 | +5.6% | 305,570 | +3.9% | 0.03% | 0.0% |
| Q2 2017 | $24,812,000 | -0.5% | 294,026 | +0.9% | 0.03% | -3.6% |
| Q1 2017 | $24,925,000 | +9.8% | 291,415 | -0.1% | 0.03% | +7.7% |
| Q4 2016 | $22,701,000 | -2.5% | 291,624 | -1.8% | 0.03% | -3.7% |
| Q3 2016 | $23,276,000 | -28.7% | 296,917 | -8.2% | 0.03% | -28.9% |
| Q2 2016 | $32,651,000 | +6.3% | 323,280 | -0.1% | 0.04% | +5.6% |
| Q1 2016 | $30,704,000 | +2.0% | 323,690 | -0.1% | 0.04% | +2.9% |
| Q4 2015 | $30,090,000 | +10.0% | 323,957 | +0.9% | 0.04% | +6.1% |
| Q3 2015 | $27,365,000 | -2.3% | 321,147 | -1.9% | 0.03% | +6.5% |
| Q2 2015 | $28,005,000 | -0.2% | 327,205 | -1.0% | 0.03% | 0.0% |
| Q1 2015 | $28,072,000 | +7.5% | 330,649 | +8.5% | 0.03% | +6.9% |
| Q4 2014 | $26,111,000 | +11.8% | 304,643 | -0.9% | 0.03% | +3.6% |
| Q3 2014 | $23,361,000 | +8.9% | 307,448 | +12.9% | 0.03% | +3.7% |
| Q2 2014 | $21,446,000 | -1.5% | 272,428 | -6.2% | 0.03% | -6.9% |
| Q1 2014 | $21,777,000 | -4.1% | 290,365 | -1.3% | 0.03% | -3.3% |
| Q4 2013 | $22,718,000 | +4.1% | 294,262 | -6.5% | 0.03% | -6.2% |
| Q3 2013 | $21,826,000 | +5.7% | 314,857 | -3.5% | 0.03% | +6.7% |
| Q2 2013 | $20,649,000 | – | 326,201 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |